liver health
Research Roundup
Debbie Rigby rounds up the latest in research news Electronic cigarettes and health outcomes An umbrella and systematic review of the global evidence has concluded that E‐cigarettes can be harmful …
The week in review
As the COVID-19 crisis in NSW continues, there’s been plenty happening in the pharmacy sector this week More and more pharmacies were added to the list of COVID-19 exposure sites …
$11m unlawful advertising penalty sets a record
A supplier of unapproved sports supplements has been told to pay $11 million, as the TGA points out their potential to damage health The Federal Court of Australia has ordered …
Research Roundup
Debbie Rigby takes a look at the latest in research news Inhaled budesonide in the treatment of early COVID-19 (STOIC) A randomised controlled trial (Steroids in COVID-19; STOIC) of inhaled …
Valerian under scrutiny
The TGA is investigating the safety of Valerian following a small number of reports of liver injury Noting common uses for Valeriana officinalis – such as to help manage nervousness, …
The week in review
With many of Australia’s pharmacists descending on Sydney to attend the PSA19 conference, it’s been a very busy week in the world of pharmacy… At the conference, Health Minister Greg …
Clinical tips: Hepatitis C elimination
What impact can pharmacists have on the uptake of DAAs? asks Carlene McMaugh Hepatitis C is now in a unique category of conditions where we have a medication that can …
‘Substantive evidence’ on HCV cure benefits
Direct-acting antivirals are associated with reduced risk of mortality and liver cancer, according to results from the first prospective, longitudinal study investigating their use in treating chronic hepatitis C The …
‘This is life-changing news.’
Deaths from hepatitis C have dropped by a fifth, highlighting the importance of new treatments and their affordability New Kirby Institute data presented at the Australasian Viral Hepatitis Conference in …
Hepatitis patients need to ‘just ask’
The number of Australians receiving breakthrough antiviral therapy to cure hepatitis C has sharply declined This has prompted appeals for more Australians living with the virus to come forward to …
Guild, Gilead launch Hep C course
Guild Learning and Development is partnering with Gilead Sciences in an online course The course is titled Management of Hepatitis C and the role of pharmacy. Hepatitis C (HCV), a …
PBS listing for first pan-genotypic antiviral hep C treatment
Hepatitis Australia has welcomed today’s announcement that a new hepatitis C drug will be listed on the PBS Epclusa, the first pan-genotypic antiviral, will be PBS listed from 1 August, …